# A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines

> **NCT06308198** · PHASE3 · COMPLETED · sponsor: **AbbVie** · enrollment: 161 (actual)

## Conditions studied

- Glabellar Lines

## Interventions

- **DRUG:** AGN-151586
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06308198
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-29
- **Primary completion:** 2025-02-26
- **Final completion:** 2025-02-26
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06308198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06308198, "A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06308198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*